Brazil's Anvisa Approves Oral Wegovy, Expanding Obesity Treatment Access
Published 1 d ago1 sourceEvidence: Reported
Omni, a Brazilian pharmaceutical insurance provider, closed a funding round led by ACNext with participation from existing investors GreenRock and Enseada. The company plans to double its customer base and reach R$ 50 million in revenue by end of next year. This signals growth in Brazil's niche health-related insurance market, but the round's size and valuation are undisclosed.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 9 h ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 46 min ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 11 h ago1 sourceEvidence: Reported